Sharon L. Davis
Sharon L. Davis has extensive experience in all aspects of intellectual property litigation in United States District Courts and before the United States Court of Appeals for the Federal Circuit. Ms. Davis’ patent litigation experience spans a wide range of technical fields including Internet technology, e-commerce and pharmaceutical patents. Ms. Davis has particular expertise in Hatch-Waxman litigation.
Ms. Davis was born in Huntsville, Alabama and received a B.S. degree from Birmingham-Southern College, summa cum laude, in 1988. She received her J.D. degree from the University of Chicago Law School, with highest honors, in 1991. While at the University of Chicago, Ms. Davis was an Associate Articles Editor of the University of Chicago Law Review and published "Drug Kingpins and Their Helpers: Accomplice Liability Under 21 USC Section 848," 58 U. Chi. Law Rev. 391 (1991).
Following a clerkship with the Honorable Patrick Higginbotham of the United States Court of Appeals for the Fifth Circuit, Ms. Davis was a litigator with Williams & Connolly LLP in Washington, D.C., where she worked on a wide variety of lawsuits and litigation matters. Ms. Davis has been litigating patent cases since 1997.
Ms. Davis was admitted to the Bar of the State of Texas in 1991 and the Bar of the District of Columbia in 1992. She is also admitted to practice before the United States Court of Appeals for the Federal Circuit and the Fourth Circuit; and the United States District Courts for the District of Columbia and Maryland. Ms. Davis is a member of the Women’s Bar Association of the District of Columbia and the American Bar Association. Ms. Davis has been ranked in the IAM Patent 1000 (2014-2016) for the DC Metro Area and listed in the "Washington DC Super Lawyers" list (2013-2017).
In the area of patent litigation, Ms. Davis advises clients on litigation strategy with respect to infringement, validity and unenforceability issues. She has handled Hatch-Waxman litigations relating to, inter alia, fentanyl transdermal patches, paclitaxel, levalbuterol, and levocetirizine. Representative litigation matters in other areas of technology include Affinion Net Patents, Inc. v. Maritz, Inc. in the District of Delaware; Guardian Industries, Inc. v. AFG Industries, Inc. in the Eastern District of Michigan and Dow Jones & Company, Inc. v. Ablaise, Ltd. in the District of Columbia.